National Committee on Vital and Health Statistics: Teleconference, 24728-24729 [2014-09903]

Download as PDF 24728 Federal Register / Vol. 79, No. 84 / Thursday, May 1, 2014 / Notices Manager and the Secretary will keep the Committee informed of ongoing developments regarding the System’s balance sheet that could affect the attainment over time of the Committee’s objectives of maximum employment and price stability. 2. Legend Bank Employee Stock Ownership Plan and 401(k) Plan (As Amended and Restated Generally Effective as of June 19, 2012), Bowie, Texas; to retain, and to acquire, additional voting shares of Legend Bancorp, Inc., and thereby indirectly retain, and acquire additional voting shares of Legend Bank, N.A., Bowie, Texas. Board of Governors of the Federal Reserve System, April 28, 2014. Michael J. Lewandowski, Associate Secretary of the Board. By order of the Federal Open Market Committee, April 10, 2014. William B. English, Secretary, Federal Open Market Committee. percent of the voting shares of Algodon de Calidad Bancshares, Inc., and The First State Bank, both in Abernathy, Texas. Board of Governors of the Federal Reserve System, April 28, 2014. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2014–09955 Filed 4–30–14; 8:45 am] BILLING CODE 6210–01–P [FR Doc. 2014–09905 Filed 4–30–14; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6210–01–P FEDERAL RESERVE SYSTEM FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies National Committee on Vital and Health Statistics: Teleconference [FR Doc. 2014–09957 Filed 4–30–14; 8:45 am] Federal Open Market Committee; Domestic Policy Directive of March 18– 19, 2014 tkelley on DSK3SPTVN1PROD with NOTICES In accordance with Section 271.25 of its rules regarding availability of information (12 CFR part 271), there is set forth below the domestic policy directive issued by the Federal Open Market Committee at its meeting held on March 18–19, 2014.1 Consistent with its statutory mandate, the Federal Open Market Committee seeks monetary and financial conditions that will foster maximum employment and price stability. In particular, the Committee seeks conditions in reserve markets consistent with federal funds trading in a range from 0 to 1⁄4 percent. The Committee directs the Desk to undertake open market operations as necessary to maintain such conditions. Beginning in April, the Desk is directed to purchase longer-term Treasury securities at a pace of about $30 billion per month and to purchase agency mortgage-backed securities at a pace of about $25 billion per month. The Committee also directs the Desk to engage in dollar roll and coupon swap transactions as necessary to facilitate settlement of the Federal Reserve’s agency mortgage-backed securities transactions. The Committee directs the Desk to maintain its policy of rolling over maturing Treasury securities into new issues and its policy of reinvesting principal payments on all agency debt and agency mortgage-backed securities in agency mortgage-backed securities. The System Open Market Account 1 Copies of the Minutes of the Federal Open Market Committee at its meeting held on March 18– 19, 2014, which includes the domestic policy directive issued at the meeting, are available upon request to the Board of Governors of the Federal Reserve System, Washington, DC 20551. The minutes are published in the Federal Reserve Bulletin and in the Board’s Annual Report. VerDate Mar<15>2010 17:30 Apr 30, 2014 Jkt 232001 The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than May 27, 2014. A. Federal Reserve Bank of Dallas (E. Ann Worthy, Vice President) 2200 North Pearl Street, Dallas, Texas 75201– 2272: 1. AHB Bancshares, Inc., Clovis, New Mexico; to become a bank holding company by acquiring 100 percent of the voting shares of American Heritage Bank, Clovis, New Mexico. 2. Turner Bancshares, Inc., Abernathy, Texas; to become a bank holding company by acquiring 100 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting. Name: National Committee on Vital and Health Statistics (NCVHS), Full Committee Teleconference. Time and Date: 3:00 p.m.–5:00 p.m. (EDT) May 15, 2014. Place: Teleconference—scheduled to begin at 3:00 p.m. Eastern Daylight Savings Time. To participate in the teleconference, please use the following url https://www.ncvhs. hhs.gov/ to take you to the NCVHS homepage where registration information and the link to join the call will be available. Status: Open, however teleconference access limited only by availability of telephone ports. There will be a verbal comment period during the final 15 minutes of the teleconference. The public is also welcome to submit written comments in advance of the meeting to Terri Deutsch whose contact information is written below. Written comments received by May 13, 2014, will be included in the official record of the meeting. Purpose: The NCVHS has been named in the Patient Protection and Affordable Care Act (ACA) of 2010 to review and make recommendations on several operating rules and standards related to HIPAA transactions. This meeting will support these activities in the development of a set of recommendations for the Secretary, as required by § 1104 of the ACA. The purpose of this teleconference of the full committee of the NCVHS is to discuss and vote for approval three letters addressed to the Secretary of Health and Human Services. The matters to be discussed are: (1) Letter regarding the Electronic Standards for Public Health Information Exchange. The purpose of this letter is to provide observations and recommendations from the NCVHS regarding the current state of health informatics standards used by public health and population health programs; (2) A recommendation letter that focuses on the findings from the February 19, 2014 NCVHS Hearing on Prescriber Prior Authorization for Pharmacy Benefits, Health Plan Identifier (HPID), Electronic Fund Transfer (EFT)/ Electronic Remittance Advice (ERA), and E:\FR\FM\01MYN1.SGM 01MYN1 Federal Register / Vol. 79, No. 84 / Thursday, May 1, 2014 / Notices Remaining Operating Rules; and (3) A letter emphasizing NCVHS’s long-standing position on the adoption of ICD–10 code sets in the US. Contact Person for More Information: Debbie Jackson, Interim Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Room 2402, Hyattsville, Maryland 20782, telephone (301) 458–4614; Written comments should be sent directly to Terri Deutsch, lead staff for the Standards Subcommittee, NCVHS, Centers for Medicare and Medicaid Services, Office of E-Health Standards and Services, 7500 Security Boulevard, Mailstop S2–26–17, Baltimore, Maryland 21244, email Terri.Deutsch@ cms.hhs.gov, phone (410) 786–9462. Program information as well as summaries of meetings and a roster of committee members are available on the NCVHS home page of the HHS Web site: https:// www.ncvhs.hhs.gov/, where further information including an agenda will be posted when available. Dated: April 23, 2014. James Scanlon, Deputy Assistant Secretary for Planning and Evaluation, Office of the Assistant Secretary for Planning and, Evaluation. [FR Doc. 2014–09903 Filed 4–30–14; 8:45 am] Biologics’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0765. The approval expires on March 31, 2017. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. Dated: April 25, 2014. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2014–09914 Filed 4–30–14; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2013–N–1394] Food and Drug Administration, HHS. [Docket No. FDA–2013–D–0575] ACTION: Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Expedited Programs for Serious Conditions— Drugs and Biologics SUMMARY: AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Guidance for Industry on Expedited Programs for Serious Conditions—Drugs and Biologics’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 1350 Piccard Dr., PI50–400B, Rockville, MD 20850, PRAStaff@fda.hhs.gov. SUPPLEMENTARY INFORMATION: On December 31, 2013, the Agency submitted a proposed collection of information entitled ‘‘Guidance for Industry on Expedited Programs for Serious Conditions—Drugs and tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:30 Apr 30, 2014 Jkt 232001 Dated: April 25, 2014. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2014–09913 Filed 4–30–14; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2013–N–0338] Center for Devices and Radiological Health: Experiential Learning Program AGENCY: ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: Food and Drug Administration the Internet at https://www.reginfo.gov/ public/do/PRAMain. Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Guidance for Industry on Special Protocol Assessment’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 1350 Piccard Dr., PI50–400B, Rockville, MD 20850, PRAStaff@fda.hhs.gov. SUPPLEMENTARY INFORMATION: On February 19, 2014, the Agency submitted a proposed collection of information entitled ‘‘Guidance for Industry on Special Protocol Assessment’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0470. The approval expires on March 31, 2017. A copy of the supporting statement for this information collection is available on PO 00000 Frm 00063 Fmt 4703 Food and Drug Administration, HHS. Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Special Protocol Assessment BILLING CODE 4151–05–P 24729 Sfmt 4703 Notice. The Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH or Center) is announcing an invitation for participation in its Experiential Learning Program (ELP). The ELP provides a formal training mechanism for regulatory review staff to visit research, clinical, manufacturing, and health care facilities to observe firsthand how medical devices are designed, developed, and utilized. This training is intended to provide CDRH staff with an opportunity to observe the device development life cycle and provide a better understanding of the medical devices they review and the challenges faced throughout development, testing, manufacturing, and clinical use. The purpose of this document is to invite medical device industry, academia, and health care facilities to participate in this formal training program for FDA’s medical device review staff, or to contact CDRH for more information regarding the program. DATES: Submit either an electronic or written request for participation in this program by June 2, 2014. The request should include a description of your facility relative to product areas regulated by CDRH. Please include the Area of Interest (see table 1 or 2) that the site visit will demonstrate to CDRH staff, a contact person, site visit location, length of site visit, proposed dates, and maximum number of CDRH staff that can be accommodated during a site visit. Submitted proposals without this information will not be considered. In addition, please include an agenda outlining the proposed training for the site visit. A sample request and agenda are available on the ELP Web site: https://www.fda.gov/downloads/ ScienceResearch/ SUMMARY: E:\FR\FM\01MYN1.SGM 01MYN1

Agencies

[Federal Register Volume 79, Number 84 (Thursday, May 1, 2014)]
[Notices]
[Pages 24728-24729]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09903]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Committee on Vital and Health Statistics: Teleconference

    Pursuant to the Federal Advisory Committee Act, the Department of 
Health and Human Services (HHS) announces the following advisory 
committee meeting.

    Name: National Committee on Vital and Health Statistics (NCVHS), 
Full Committee Teleconference.
    Time and Date: 3:00 p.m.-5:00 p.m. (EDT) May 15, 2014.
    Place: Teleconference--scheduled to begin at 3:00 p.m. Eastern 
Daylight Savings Time. To participate in the teleconference, please 
use the following url https://www.ncvhs.hhs.gov/ to take you to the 
NCVHS homepage where registration information and the link to join 
the call will be available.
    Status: Open, however teleconference access limited only by 
availability of telephone ports. There will be a verbal comment 
period during the final 15 minutes of the teleconference. The public 
is also welcome to submit written comments in advance of the meeting 
to Terri Deutsch whose contact information is written below. Written 
comments received by May 13, 2014, will be included in the official 
record of the meeting.
    Purpose: The NCVHS has been named in the Patient Protection and 
Affordable Care Act (ACA) of 2010 to review and make recommendations 
on several operating rules and standards related to HIPAA 
transactions. This meeting will support these activities in the 
development of a set of recommendations for the Secretary, as 
required by Sec.  1104 of the ACA.
    The purpose of this teleconference of the full committee of the 
NCVHS is to discuss and vote for approval three letters addressed to 
the Secretary of Health and Human Services. The matters to be 
discussed are: (1) Letter regarding the Electronic Standards for 
Public Health Information Exchange. The purpose of this letter is to 
provide observations and recommendations from the NCVHS regarding 
the current state of health informatics standards used by public 
health and population health programs; (2) A recommendation letter 
that focuses on the findings from the February 19, 2014 NCVHS 
Hearing on Prescriber Prior Authorization for Pharmacy Benefits, 
Health Plan Identifier (HPID), Electronic Fund Transfer (EFT)/
Electronic Remittance Advice (ERA), and

[[Page 24729]]

Remaining Operating Rules; and (3) A letter emphasizing NCVHS's 
long-standing position on the adoption of ICD-10 code sets in the 
US.
    Contact Person for More Information: Debbie Jackson, Interim 
Executive Secretary, NCVHS, National Center for Health Statistics, 
Centers for Disease Control and Prevention, 3311 Toledo Road, Room 
2402, Hyattsville, Maryland 20782, telephone (301) 458-4614; Written 
comments should be sent directly to Terri Deutsch, lead staff for 
the Standards Subcommittee, NCVHS, Centers for Medicare and Medicaid 
Services, Office of E-Health Standards and Services, 7500 Security 
Boulevard, Mailstop S2-26-17, Baltimore, Maryland 21244, email 
Terri.Deutsch@cms.hhs.gov, phone (410) 786-9462.
    Program information as well as summaries of meetings and a 
roster of committee members are available on the NCVHS home page of 
the HHS Web site: https://www.ncvhs.hhs.gov/, where further 
information including an agenda will be posted when available.

    Dated: April 23, 2014.
James Scanlon,
Deputy Assistant Secretary for Planning and Evaluation, Office of the 
Assistant Secretary for Planning and, Evaluation.
[FR Doc. 2014-09903 Filed 4-30-14; 8:45 am]
BILLING CODE 4151-05-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.